Abstract
Selinexor (XPOVIO (TM)) is a first-in-class, oral, small molecule Exportin-1 (XPO1) inhibitor that is being developed by Karyopharm Therapeutics for t......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
